Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
02/2012
02/16/2012WO2011137925A9 New pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumors
02/16/2012WO2011134444A9 Substitution derivatives of n6-benzyladenosine-5´-monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparation containing these compounds
02/16/2012WO2011127058A9 Biomarkers for mdm2 inhibitors for use in treating disease
02/16/2012WO2011116014A9 Humanized antibodies to labyrinthin and uses thereof
02/16/2012WO2011115688A3 Integrin interaction inhibitors for the treatment of cancer
02/16/2012WO2010141796A3 PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
02/16/2012WO2010054606A3 Triperpenoid 2 - deoxy glycosides and use thereof as medicaments
02/16/2012WO2002085309A9 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
02/16/2012US20120042399 Immunogenic peptides
02/16/2012US20120041397 Method of treatment of premalignant and malignant skin lesions with cytotoxic agents
02/16/2012US20120041357 Method of controlled drug release from a liposome carrier
02/16/2012US20120041274 Cancer biomarkers
02/16/2012US20120041070 Methods of treating cancer having an aberrant egfr or kras genotype
02/16/2012US20120041067 Methods of Inducing Terminal Differentiation
02/16/2012US20120041063 Antitumoral compounds
02/16/2012US20120041056 Nucleic acids specifically binding with human factor vii/viia and uses thereof
02/16/2012US20120041055 Composite polynucleic acid therapeutics
02/16/2012US20120041054 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction
02/16/2012US20120041048 COMPOSITIONS AND METHODS RELATING TO miR-31
02/16/2012US20120041046 Non-steroidal compounds for androgen receptor modulation
02/16/2012US20120041045 Use of pharmaceutical compositions containing mesembrenone
02/16/2012US20120041032 Metalloprotein inhibitors
02/16/2012US20120041030 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
02/16/2012US20120041017 Pyridocarbazole type compounds and applications thereof
02/16/2012US20120041007 Cdk inhibitor salts
02/16/2012US20120041002 Substituted pyrazolo [1,5-a] pyrimidines as metabotropic glutamate antagonists
02/16/2012US20120041001 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
02/16/2012US20120041000 Imidazo [1,2-a]pyridine derivatives as fgfr kinase inhibitors for use in therapy
02/16/2012US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses
02/16/2012US20120040995 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
02/16/2012US20120040993 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
02/16/2012US20120040992 Oligooxopiperazines and methods of making and using them
02/16/2012US20120040988 DERIVATIVES OF 6,7-DIHYDRO-3H-OXAZOLO[3,4-a]PYRAZINE-5,8-DIONE
02/16/2012US20120040987 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
02/16/2012US20120040986 Omega carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
02/16/2012US20120040984 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
02/16/2012US20120040981 Thienopyrimidine as cdc7 kinase inhibitors
02/16/2012US20120040974 Mif modulators
02/16/2012US20120040971 Benzodiazepinone compounds useful in the treatment of skin conditions
02/16/2012US20120040968 Diamino heterocyclic carboxamide compound
02/16/2012US20120040967 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use
02/16/2012US20120040961 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
02/16/2012US20120040960 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
02/16/2012US20120040955 Fluoro substituted pyrimidine compounds as jak3 inhibitors
02/16/2012US20120040951 Heteroaryl compounds useful as raf kinase inhibitors
02/16/2012US20120040937 Compounds for the treatment of proliferative disorders
02/16/2012US20120040928 Methods and compositions for inhibiting cellular proliferation and surgical adhesion
02/16/2012US20120040925 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
02/16/2012US20120040923 Stable s-adenosyl-l-methionine
02/16/2012US20120040918 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
02/16/2012US20120040915 Peptides and nanoparticles for therapeutic and diagnostic applications
02/16/2012US20120040914 Enhancing effectiveness of glial cancer therapies
02/16/2012US20120040900 Compositions of and methods of using ligand dimers
02/16/2012US20120040897 Novel derivatives of acyl cyanopyrrolidines
02/16/2012US20120040896 Compositions, methods and uses for modulation of brca 1
02/16/2012US20120040892 Methods and Compositions for the Treatment of Heart Failure and Other Disorders
02/16/2012US20120040886 Analogues of Neuropeptide Y Having Proline Substitution At Position 34
02/16/2012US20120040885 Analogues of Neuropeptide Y Having At Least One Synthetic Amino Acid Substitution
02/16/2012US20120040033 Anti-infective mangrove extract against viruses, bacteria and fungi
02/16/2012US20120040026 Aromatase inhibitor
02/16/2012US20120040022 Gallium compositions for the treatment of liver cancer and methods of use
02/16/2012US20120040021 Methods and compositions for the treatment of cancer
02/16/2012US20120040020 Compounds useful as inhibitors of atr kinase
02/16/2012US20120039995 Arsenic compounds, their preparation methods and uses thereof
02/16/2012US20120039993 Detection of Gene Expression
02/16/2012US20120039990 Liposome Compositions and Methods of Use Thereof
02/16/2012US20120039989 Erythrocyte-binding therapeutics
02/16/2012US20120039988 Cancer-targeting peptides and uses thereof in cancer therapy
02/16/2012US20120039987 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
02/16/2012US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
02/16/2012US20120039984 Glycopeptide and uses thereof
02/16/2012US20120039983 Amphiphilic macromolecule-lipid complexes
02/16/2012US20120039946 Immunopotentiating composition and process for producing same
02/16/2012US20120039943 Factors
02/16/2012US20120039941 Engineered botulinum neurotoxin
02/16/2012US20120039940 Methods for treating uterine disorders
02/16/2012US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
02/16/2012US20120039932 Lentiviral Vectors Pseudotyped with a Sindbis Virus Envelope Glycoprotein
02/16/2012US20120039931 Dna composition encoding an immunogenic vegf receptor peptide and methods of use thereof
02/16/2012US20120039928 Medicinal plants extract using processing of herbal medicine and composition of skin external application comprising the same
02/16/2012US20120039926 Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells
02/16/2012US20120039915 Glioblastoma multiforme-reactive antibodies and methods of use thereof
02/16/2012US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor
02/16/2012US20120039912 Rspondin-3 inhibition in bone disorders
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039904 Anti system asc amino acid transporter 2 (asct2) antibody
02/16/2012US20120039902 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
02/16/2012US20120039901 Method for the prevention and treatment of cancer by inhibition of gpvi
02/16/2012US20120039893 Mutant smoothened and methods of using the same
02/16/2012US20120039892 A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
02/16/2012US20120039891 Methods for diagnosing cancer and decreasing metastasis by cancer cells
02/16/2012US20120039889 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
02/16/2012US20120039887 Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
02/16/2012US20120039885 Composition and method for cancer treatment
02/16/2012US20120039884 Compositions and methods for treating cardiovascular disease
02/16/2012US20120039875 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
02/16/2012US20120039871 Methods and compositions for antibody therapy
02/16/2012US20120039869 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
02/16/2012US20120039861 Identification of extracellular form of pten that can be used to treat tumors
02/16/2012US20120039844 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation
1 ... 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 ... 2211